Recombinant Bovine LZM Protein，His

LZM (lysozyme) recombinant proteins have garnered significant attention in biomedical research due to their enzymatic properties and potential therapeutic applications. Lysozyme, an enzyme found in various biological fluids, functions by hydrolyzing the glycosidic bonds in bacterial cell walls, thereby exhibiting antimicrobial activity. The advent of recombinant DNA technology has facilitated the production of LZM in various host systems, including bacteria, yeast, and cell cultures, ensuring high yields and consistent quality. Research has primarily focused on enhancing the stability and activity of lysozyme variants, tailoring them for specific applications such as food preservation, pharmaceutical formulations, and as an adjuvant in vaccines. Furthermore, LZM’s role in innate immunity has inspired investigations into its potential as an immunomodulator, opening avenues for therapeutic interventions in inflammatory conditions and infections. The ability to produce LZM in a sustainable and efficient manner through recombinant methods not only addresses the limitations of natural sourcing but also allows for the exploration of engineered variants with improved properties. As such, the study of LZM recombinant proteins stands at the intersection of enzyme technology, microbiology, and therapeutic innovation, highlighting their importance in both fundamental research and practical applications in health and medicine.